X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.globenewswire.com/news-release/2020/02/24/1989107/0/en/Paratek-Announces-License-Grant-to-Almirall-for-SEYSARA-sarecycline-for-Greater-China-Region.html
https://www.prnewswire.com/news-releases/almirall-llc-announces-the-publication-of-long-term-safety-data-for-the-use-of-seysara-sarecycline-tablets-in-patients-9-years-of-age-and-older-300970843.html
https://www.fool.com/investing/2018/10/04/why-barnes-noble-paratek-pharmaceuticals-and-horto.aspx
https://www.fiercepharma.com/marketing/2-paratek-antibiotics-win-fda-nods-one-slated-for-500m-peak-sales
http://www.pharmatimes.com/news/green_light_for_acne_drug_seysara_in_the_us_1254328
https://www.prnewswire.com/news-releases/almirall-acquires-allergan-us-medical-dermatology-portfolio-300716808.html
http://www.pharmatimes.com/news/almirall_acquires_allergans_us_dermatology_portfolio_for_$650_million_1246917
http://phx.corporate-ir.net/phoenix.zhtml?c=253770&p=irol-newsArticle&ID=2355307
http://phx.corporate-ir.net/phoenix.zhtml?c=253770&p=irol-newsArticle&ID=2324587
Market Place
Share 
